Cornerstone Capital Management Holdings’s Agios Pharmaceuticals AGIO Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,917	Closed	-$159K	–	1376
2016 Q1	$159K	Sell	3,917 -6,954	-64%	-$297K	﹤0.01%	1247
2015 Q4	$706K	Sell	10,871 -5,579	-34%	-$366K	0.01%	969
2015 Q3	$1.16M	Buy	+16,450	New	+$1.61M	0.01%	846
2015 Q2	–	Sell	-900	Closed	-$85K	–	1405
2015 Q1	$85K	Hold	900	–	–	﹤0.01%	1279
2014 Q4	$101K	Buy	+900	New	+$80.4K	﹤0.01%	1160

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

FV2GP

Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Cornerstone Capital Management Holdings's AGIO Position: Q2 2016 in Review

Cornerstone Capital Management Holdings sold out of Agios Pharmaceuticals (AGIO) in Q2 2016, closing a stake of 3,917 shares — an estimated $159K sold.

Cornerstone Capital Management Holdings first reported a position in AGIO in Q4 2014 and held it in 5 quarters. The position peaked at $1.16M in Q3 2015. 156 funds tracked by Wall St. Rank hold AGIO as of Q2 2016.

Cornerstone Capital Management Holdings reported no remaining Agios Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 3,917 Agios Pharmaceuticals shares in Q2 2016, an estimated $159K.
Cornerstone Capital Management Holdings first reported a position in Agios Pharmaceuticals in Q4 2014 and held it in 5 quarters.
Cornerstone Capital Management Holdings's Agios Pharmaceuticals position peaked at $1.16M in Q3 2015.
156 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2016.

Based on Cornerstone Capital Management Holdings's 13F filing for Q2 2016, filed 12 Aug 2016.